Are Lessons Learned in Setting Cut Points for Detection of Anti-Drug Antibodies Also Useful in Serology Assays for Robust Detection of SARS-CoV-2 Reactive Antibodies?

Saved in:

Bibliographic Details
Published in:	The AAPS journal Vol. 22; no. 6; p. 127
Main Authors:	Bowsher, Ronald R., Devanarayan, Viswanath
Format:	Journal Article
Language:	English
Published:	Cham Springer International Publishing 06-10-2020
Subjects:	Antibodies - blood Antibodies, Viral - blood Antibodies, Viral - immunology Antigens, Viral - immunology Betacoronavirus - immunology Biochemistry Biomedical and Life Sciences Biomedicine Biotechnology Clinical Laboratory Techniques - methods Commentary Coronavirus Infections - diagnosis COVID-19 COVID-19 Testing Drug Hypersensitivity - blood Drug Hypersensitivity - diagnosis Endpoint Determination - methods Endpoint Determination - standards Enzyme-Linked Immunosorbent Assay - methods Enzyme-Linked Immunosorbent Assay - standards False Negative Reactions False Positive Reactions Humans Normal Distribution Pandemics Pharmacology/Toxicology Pharmacy Pneumonia, Viral - diagnosis Point-of-Care Testing Reproducibility of Results SARS-CoV-2 Sensitivity and Specificity Spike Glycoprotein, Coronavirus - immunology COVID-19 diagnostics cut point immunogenicity serology statistics
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Bibliography:	ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23
ISSN:	1550-7416 1550-7416
DOI:	10.1208/s12248-020-00510-8